Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

BACKGROUND: The current paradigm for cord blood transplantation is that HLA matching and immune suppression are strictly required to prevent graft versus host disease (GVHD). Immunological arguments and historical examples have been made that the use of cord blood for non-hematopoietic activities su...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wan-Zhang, Zhang, Yun, Wu, Fang, Min, Wei-Ping, Minev, Boris, Zhang, Min, Luo, Xiao-Ling, Ramos, Famela, Ichim, Thomas E, Riordan, Neil H, Hu, Xiang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922090/
https://www.ncbi.nlm.nih.gov/pubmed/20682053
http://dx.doi.org/10.1186/1479-5876-8-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922090/
https://www.ncbi.nlm.nih.gov/pubmed/20682053
http://dx.doi.org/10.1186/1479-5876-8-75

Ejemplares similares